Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled, dose ranging pilot study to examine
the effects of conivaptan in patients with acute decompensated heart failure.